Remarkably, in one of these studies, two out of five evaluable patients revealed no additional cytogenetic or molecular alterations at the moment of AML diagnosis, highlighting the exclusive appearance of the NPM1 mutation [48]. Here, NPM1 is linked to acute myeloid leukemia.